Significance of HLA nondependent risk factors of chronic transplant nephropathy for the development of endothelial dysfunction after kidney transplantation.
More than 40% of renal allografts show chronic transplant nephropathy (CTN) early after renal transplantation. Cardiovascular disease is the leading cause of death in this population. Thus endothelial dysfunction represents an early angiopathy causing CTN and atherosclerosis. We sought to evaluate changes in endothelial dysfunction and vascular wall thickness during the first year posttransplantation as well as their association with HLA nondependent risk factors for CTN. At 3 and 52 weeks after grafting, we studied 25 patients without overt atherosclerotic disease and acute posttransplant complications for von Willebrand factor (vWF), plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA), big endothelin-1 (ET-1), flow-mediated dilatation (FMD), intimal media thickness (IMT), serum total cholesterol (TC), and triglycerides (TAG). FMD and IMT at 52 weeks showed significant correlations (P < .05) with recipient age, and the FMD ratios at 3 and 52 weeks correlated with the time on hemodialysis. Recipient age was significantly correlated with TC and PAI-1 with TAG. vWF was the only parameter that significantly correlated with donor age. There were no significant correlations with creatinine clearance. Decreased TAG approached statistical significance (P = .07) and TC decreased nonsignificantly. The worsening of FMD and ET-1 was not significant. A nonsignificant improvement in IMT was not associated with any analyzed parameters. Our results implied that the time on hemodialysis, the presence of hyperlipoproteinemia, and the recipient age significantly contributed to endothelial dysfunction during the first year after transplantation.
Horcicka
V
V
Third Department of Internal Medicine, Olomouc, Czech Republic. horcickj@fnol.cz
Zadrazil
J
J
Karasek
D
D
Al Jabry
S
S
Krejci
K
K
Strebl
P
P
Halenka
M
M
Elfmark
M
M
D000328:Adult; D001706:Biopsy; D001916:Brachial Artery / Q000473:pathology; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000503:physiopathology; D002339:Carotid Arteries / Q000473:pathology; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000378:metabolism; D004108:Dilatation, Pathologic; D004730:Endothelium, Vascular / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006680:HLA Antigens / Q000276:immunology*; D006801:Humans; D007674:Kidney Diseases / Q000601:surgery; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology*; D006435:Renal Dialysis; D012307:Risk Factors; D014019:Tissue Donors / Q000706:statistics & numerical data; D014184:Transplantation, Homologous; D014280:Triglycerides / Q000097:blood; D017540:Tunica Media / Q000473:pathology*
D006680:HLA Antigens; D014280:Triglycerides; D002784:Cholesterol; D003404:Creatinine